Uy GL, Newell LF, Lin TL, et al. Transplant outcomes after CPX-351 vs 7 + 3 in older adults with newly diagnosed high-risk and/or secondary AML. Blood Adv. 2022;6(17):4989-4993.

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2023
Materias:
Erratum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10333738/
https://www.ncbi.nlm.nih.gov/pubmed/37318935
http://dx.doi.org/10.1182/bloodadvances.2023010005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10333738/
https://www.ncbi.nlm.nih.gov/pubmed/37318935
http://dx.doi.org/10.1182/bloodadvances.2023010005

Ejemplares similares